美国儿科学会。药物委员会。评估儿科人群药物的研究伦理行为指南。 - Suppr

Suppr

超能文献

American Academy of Pediatrics. Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations.

出版信息

Pediatrics. 1977 Jul;60(1):91-101.

PMID:876741

Abstract

摘要

相似文献

American Academy of Pediatrics. Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations.美国儿科学会。药物委员会。评估儿科人群药物的研究伦理行为指南。

Pediatrics. 1977 Jul;60(1):91-101.

Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs, American Academy of Pediatrics.评估儿科人群药物的研究伦理行为指南。美国儿科学会药物委员会。

Pediatrics. 1995 Feb;95(2):286-94.

A researcher's concern with ethics in human research.一位研究者对人类研究中伦理道德问题的关注。

J Calif Alliance Ment Ill. 1994;5(1):6-8.

Nondevelopmental research on human subjects: the impact of the recommendations of the National Commission.关于人类受试者的非发育性研究：国家委员会建议的影响

Fed Proc. 1977 Sep;36(10):2359-64.

Development of drug therapy for children.儿童药物治疗的发展。

Fed Proc. 1977 Sep;36(10):2356-8.

Proposed guidelines for the participation of persons with dementia as research subjects.关于痴呆症患者作为研究对象参与研究的拟议指南。

Perspect Biol Med. 1995 Winter;38(2):319-61.

An IRB member's perspective on access to innovative therapy.一位机构审查委员会成员对获得创新疗法的看法。

Albany Law Rev. 1994;57(3):559-81.

Regulating research on the terminally ill: a proposal for heightened safeguards.规范对绝症患者的研究：加强保障措施的建议。

J Contemp Health Law Policy. 1999 Spring;15(2):479-524.

Do medical student research subjects need special protection?医学生研究对象需要特殊保护吗？

IRB. 1985 May-Jun;7(3):1-4.

Ethical issues related to clinical pharmacy research. American College of Clinical Pharmacy.临床药学研究相关的伦理问题。美国临床药学会。

Pharmacotherapy. 1993 Sep-Oct;13(5):523-30.

引用本文的文献

Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies.儿科药物研发：通过追踪创新疗法审视挑战与机遇。

Pharmaceutics. 2023 Oct 6;15(10):2431. doi: 10.3390/pharmaceutics15102431.

Improving Drug Therapy for Pediatric Patients: Unfinished History of Pediatric Drug Development.改善儿科患者的药物治疗：儿科药物研发的未竟历程。

J Pediatr Pharmacol Ther. 2023;28(1):4-9. doi: 10.5863/1551-6776-28.1.4. Epub 2023 Feb 3.

COVID-19 and Treatment and Immunization of Children-The Time to Redefine Pediatric Age Groups is Here.新型冠状病毒肺炎与儿童治疗及免疫——重新定义儿童年龄组的时候到了。

Rambam Maimonides Med J. 2021 Apr 29;12(2):e0010. doi: 10.5041/RMMJ.10433.

Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities.儿科临床终点和药效动力学生物标志物：局限性和机遇。

Paediatr Drugs. 2020 Feb;22(1):55-71. doi: 10.1007/s40272-019-00375-1.

The Challenges of Pediatric Drug Development.儿科药物研发的挑战。

Curr Ther Res Clin Exp. 2019 Jan 26;90:128-134. doi: 10.1016/j.curtheres.2019.01.007. eCollection 2019.

Are Regulatory Age Limits in Pediatric Melanoma Justified?小儿黑色素瘤的监管年龄限制合理吗？

Curr Ther Res Clin Exp. 2019 Jan 18;90:113-118. doi: 10.1016/j.curtheres.2019.01.003. eCollection 2019.

Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia.斯洛文尼亚存在问题的行业资助的新生儿期后儿科研究。

Curr Ther Res Clin Exp. 2019 Jan 18;90:86-91. doi: 10.1016/j.curtheres.2019.01.002. eCollection 2019.

Rational Use of Medicine in Children-The Conflict of Interests Story. A Review.儿童用药的合理使用——利益冲突故事。综述。

Rambam Maimonides Med J. 2019 Jul 18;10(3):e0018. doi: 10.5041/RMMJ.10371.

Pediatric melanoma-The whole (conflicts of interest) story.儿童黑色素瘤——完整的（利益冲突）故事。

Int J Womens Dermatol. 2018 Nov 19;5(2):110-115. doi: 10.1016/j.ijwd.2018.10.020. eCollection 2019 Jun.

Pediatric Melanoma and Drug Development.小儿黑色素瘤与药物研发

Children (Basel). 2018 Mar 20;5(3):43. doi: 10.3390/children5030043.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验